Erythromycin Tablet, Film Coated
Product Images NDC 55289-075

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Erythromycin (NDC 55289-075). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (55289075)

Image (55289075)
Label for Erythromycin Base USP 250 mg film-coated tablets, containing 3 tablets. The label shows the NDC 55289-075-03 and is packaged by PD-Rx Pharmaceuticals, Inc., Oklahoma City, OK. It includes a warning to keep out of reach of children and instructions to see the package insert for dosage and storage. The lot is SAMPLE and expiration date is 01/2050.*
FDA Label Image

Chemical Structure (Erythromycin 01)

Chemical Structure (Erythromycin 01)
Chemical structure of erythromycin, showing its complex macrolide ring with attached sugar moieties and side groups as depicted in the diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.